Zolopa AR - Search Results

1

Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral.

Pilote L, Tulsky JP, Zolopa AR, Hahn JA, Schecter GF, Moss AR. Pilote L, et al. Among authors: zolopa ar. Arch Intern Med. 1996 Jan 22;156(2):161-5. Arch Intern Med. 1996. PMID: 8546549 Clinical Trial.

2

HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample.

Zolopa AR, Hahn JA, Gorter R, Miranda J, Wlodarczyk D, Peterson J, Pilote L, Moss AR. Zolopa AR, et al. JAMA. 1994 Aug 10;272(6):455-61. JAMA. 1994. PMID: 8040981

3

Association between time homeless and perceived health status among the homeless in San Francisco.

White MC, Tulsky JP, Dawson C, Zolopa AR, Moss AR. White MC, et al. Among authors: zolopa ar. J Community Health. 1997 Aug;22(4):271-82. doi: 10.1023/a:1025152403545. J Community Health. 1997. PMID: 9247850

4

Progressive immunodeficiency due to infection with human immunodeficiency virus does not lead to waning immunity to measles in a cohort of homosexual men.

Zolopa AR, Kemper CA, Shiboski S, Hamilton JR, Moss AR, Deresinski SC. Zolopa AR, et al. Clin Infect Dis. 1994 Apr;18(4):636-8. doi: 10.1093/clinids/18.4.636. Clin Infect Dis. 1994. PMID: 8038324

5

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A. Bangsberg DR, et al. Among authors: zolopa ar. AIDS. 2000 Mar 10;14(4):357-66. doi: 10.1097/00002030-200003100-00008. AIDS. 2000. PMID: 10770537

6

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Bangsberg DR, et al. Among authors: zolopa ar. AIDS. 2001 Jun 15;15(9):1181-3. doi: 10.1097/00002030-200106150-00015. AIDS. 2001. PMID: 11416722 No abstract available.

7

High levels of adherence do not prevent accumulation of HIV drug resistance mutations.

Bangsberg DR, Charlebois ED, Grant RM, Holodniy M, Deeks SG, Perry S, Conroy KN, Clark R, Guzman D, Zolopa A, Moss A. Bangsberg DR, et al. AIDS. 2003 Sep 5;17(13):1925-32. doi: 10.1097/00002030-200309050-00011. AIDS. 2003. PMID: 12960825

8

Tuberculosis transmission in methadone maintenance programs.

Hahn JA, Zolopa AR, Moss AR, Trachtenberg AL. Hahn JA, et al. Among authors: zolopa ar. JAMA. 1995 Apr 26;273(16):1260. JAMA. 1995. PMID: 7715037 No abstract available.

9

Prevalence of antiretroviral drug resistance in the HIV-1-infected urban indigent population in San Francisco: a representative study.

Holodniy M, Charlebois ED, Bangsberg DR, Zolopa AR, Schulte M, Moss AR. Holodniy M, et al. Among authors: zolopa ar. Int J STD AIDS. 2004 Aug;15(8):543-51. doi: 10.1258/0956462041558212. Int J STD AIDS. 2004. PMID: 15307966

10

Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection.

Scherzer R, Heymsfield SB, Lee D, Powderly WG, Tien PC, Bacchetti P, Shlipak MG, Grunfeld C; Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Scherzer R, et al. AIDS. 2011 Jul 17;25(11):1405-14. doi: 10.1097/QAD.0b013e32834884e6. AIDS. 2011. PMID: 21572308 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters